あなたはここにいる:ホーム > お知らせ
09
07
2020
Date:Tuesday,September 8,2020,8:00pm-9:00pm,EDT
Location:Virtual Online
08
24
2020
Metabolite identification (MetID) plays an important role in the research and development of new drugs. During the lead optimization, the identification of metabolites can help to locate the soft spots, so that the chemists can modify the structure of the target compounds and improve their pharmacokinetic properties.
08
20
2020
Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC and Yichang Humanwell Pharmaceutical CO.LTD.
07
29
2020
The development of orally inhaled and nasal drug products (OINDP) involves a rigorous approach to formulation development, testing, stability and CMC support which are necessary to determine product efficacy, quality, safety and performance.
07
28
2020
On July 20, 2020, DAC Biotech’s new ADC drug development, TROP2-ADC---DAC-002 was approved of clinical study by NMPA. for the indication of solid malignant tumor. Medicilon completed preclinical pharmacokinetic and toxicological studies in this project, accelerating the development process.